CHEBI:149634 - dehydroemetine

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name dehydroemetine
ChEBI ID CHEBI:149634
Definition A pyridoisoquinoline which was developed in response to the cardiovascular toxicity associated with emetine and results from the dehydrogenation of the heterotricylic ring of emetine. It is an antiprotozoal agent and displays antimalarial, antiamoebic, and antileishmanial properties.
Stars This entity has been manually annotated by the ChEBI Team.
Submitter PP
Secondary ChEBI IDs CHEBI:4363
Supplier Information
Download Molfile XML SDF
more structures >>
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C29H38N2O4
Net Charge 0
Average Mass 478.633
Monoisotopic Mass 478.28316
InChI InChI=1S/C29H38N2O4/c1-6-18-17-31-10-8-20-14-27(33-3)29(35-5)16-23(20)25(31)12-21(18)11-24-22-15-28(34-4)26(32-2)13-19(22)7-9-30-24/h13-16,24-25,30H,6-12,17H2,1-5H3/t24-,25+/m1/s1
InChIKey XXLZPUYGHQWHRN-RPBOFIJWSA-N
SMILES [C@H]1(C2=C(C=C(OC)C(=C2)OC)CCN1)CC=3C[C@]4(C=5C=C(OC)C(OC)=CC5CCN4CC3CC)[H]
Roles Classification
Biological Role(s): antiprotozoal drug
Any antimicrobial drug which is used to treat or prevent protozoal infections.
antimalarial
A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human.
antileishmanial agent
An antiprotozoal drug used to treat or prevent infections caused by protozoan parasites that belong to the genus Leishmania.
Application(s): antiprotozoal drug
Any antimicrobial drug which is used to treat or prevent protozoal infections.
antimalarial
A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human.
antileishmanial agent
An antiprotozoal drug used to treat or prevent infections caused by protozoan parasites that belong to the genus Leishmania.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing dehydroemetine (CHEBI:149634) has parent hydride emetan (CHEBI:36380)
dehydroemetine (CHEBI:149634) has role antileishmanial agent (CHEBI:70868)
dehydroemetine (CHEBI:149634) has role antimalarial (CHEBI:38068)
dehydroemetine (CHEBI:149634) has role antiprotozoal drug (CHEBI:35820)
dehydroemetine (CHEBI:149634) is a aromatic ether (CHEBI:35618)
dehydroemetine (CHEBI:149634) is a isoquinolines (CHEBI:24922)
dehydroemetine (CHEBI:149634) is a pyridoisoquinoline (CHEBI:61692)
IUPAC Name
6',7',10,11-tetramethoxy-2,3-didehydroemetan
INNs Sources
dehidroemetina WHO MedNet
déhydroémétine WHO MedNet
dehydroemetine WHO MedNet
dehydroemetinum WHO MedNet
Synonyms Sources
(−)-2,3-dehydroemetine ChemIDplus
(−)-R,S-dehydroemetine ChEBI
2,3-didehydro-6',7',10,11-tetramethoxyemetan ChemIDplus
2,3-didehydroemetine ChemIDplus
2-dehydroemetine ChemIDplus
BT 436 ChemIDplus
Ro 1-9334 ChemIDplus
Ro 1-9334/19 ChemIDplus
Ro-1-9334/19 DrugBank
Ro-1933419 DrugBank
Brand Names Sources
Dametin ChEBI
Mebadin KEGG DRUG
Mebadine ChEBI
Manual Xrefs Databases
3129 DrugCentral
C07996 KEGG COMPOUND
D00828 KEGG DRUG
DB13865 DrugBank
Dehydroemetine Wikipedia
View more database links
Registry Number Type Source
4914-30-1 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
13749080 PubMed citation Europe PMC
13990811 PubMed citation Europe PMC
13991475 PubMed citation Europe PMC
14040651 PubMed citation Europe PMC
14292163 PubMed citation Europe PMC
14482399 PubMed citation Europe PMC
16732 PubMed citation Europe PMC
19879 PubMed citation Europe PMC
2202709 PubMed citation Europe PMC
2565955 PubMed citation Europe PMC
2887439 PubMed citation Europe PMC
31964796 PubMed citation Europe PMC
4113710 PubMed citation Europe PMC
4394757 PubMed citation Europe PMC
4401314 PubMed citation Europe PMC
4716643 PubMed citation Europe PMC
4916834 PubMed citation Europe PMC
6041197 PubMed citation Europe PMC
Last Modified
01 May 2020